HALOZYME HYPERCON
Live / Applied — Non-final action mailed (as of 02 Apr 2026)
What this means for you
Not registered yet, but its 17 Nov 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99501527
- Mark type
- Stylized text
- Filed
- 17 Nov 2025
- Attorney of record
- Gene K. Park
Goods and services
- Class 040 — Treatment of materials: Custom manufacture of reformulated pharmaceuticals for easier patient delivery; Custom manufacturing, processing, and treating the therapeutic molecules of others; Biomanufacturing for others, namely, manufacturing therapeutic molecules of others using biological organisms in the manufacturing process; Custom manufacture of reformulated pharmaceuticals and therapeutics
- Class 042 — Scientific and technological services: Research and development in the field of pharmaceuticals and drug delivery; scientific and medical research, namely, conducting clinical trials for others; Scientific research and design and development, namely, product design and development in the field of excipients and formulations for use with therapeutic biologics; Scientific research and design, namely product design and development in the field of therapeutic formulation development; Consulting in the fields of product design and development in the field of therapeutic formulation and excipient development; Chemical engineering in the nature of formulation and reformulation of therapeutic compositions; Development of new technology for others in the field of biomaterials, biotechnology and nanotechnology
Owner
- Halozyme, Inc., San Diego, CA, US
Prosecution history
- 02 Apr 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 02 Apr 2026 — NON-FINAL ACTION E-MAILED
- 02 Apr 2026 — NON-FINAL ACTION WRITTEN
- 25 Mar 2026 — ASSIGNED TO EXAMINER
- 12 Feb 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 17 Nov 2025 — APPLICATION FILING RECEIPT MAILED
- 17 Nov 2025 — NEW APPLICATION ENTERED